Hawkins (NASDAQ:HWKN) Now Covered by Analysts at CJS Securities

Stock analysts at CJS Securities initiated coverage on shares of Hawkins (NASDAQ:HWKN) in a research report issued on Tuesday. The brokerage set a “market outperform” rating and a $125.00 price target on the specialty chemicals company’s stock. CJS Securities’ price target indicates a potential upside of 18.27% from the company’s current price.

Separately, BWS Financial reaffirmed a “neutral” rating and issued a $122.00 price target on shares of Hawkins in a report on Friday, January 31st.

Hawkins Stock Down 0.2 %

NASDAQ:HWKN traded down $0.23 during mid-day trading on Tuesday, hitting $105.69. The stock had a trading volume of 4,601 shares, compared to its average volume of 123,424. The company has a current ratio of 2.50, a quick ratio of 1.53 and a debt-to-equity ratio of 0.23. Hawkins has a twelve month low of $71.98 and a twelve month high of $139.55. The company has a market capitalization of $2.21 billion, a PE ratio of 26.92, a PEG ratio of 3.80 and a beta of 0.77. The stock has a 50-day simple moving average of $108.74 and a two-hundred day simple moving average of $118.67.

Hawkins (NASDAQ:HWKN) last issued its earnings results on Wednesday, January 29th. The specialty chemicals company reported $0.72 EPS for the quarter, missing analysts’ consensus estimates of $0.77 by ($0.05). Hawkins had a return on equity of 18.95% and a net margin of 8.60%. On average, equities research analysts anticipate that Hawkins will post 4 EPS for the current year.

Institutional Trading of Hawkins

A number of large investors have recently bought and sold shares of the business. Vermillion Wealth Management Inc. acquired a new position in Hawkins during the fourth quarter worth about $34,000. Blue Trust Inc. lifted its holdings in shares of Hawkins by 155.4% in the fourth quarter. Blue Trust Inc. now owns 355 shares of the specialty chemicals company’s stock valued at $44,000 after purchasing an additional 216 shares in the last quarter. NewEdge Advisors LLC acquired a new stake in shares of Hawkins in the fourth quarter valued at approximately $53,000. Smartleaf Asset Management LLC increased its stake in shares of Hawkins by 262.3% during the 4th quarter. Smartleaf Asset Management LLC now owns 442 shares of the specialty chemicals company’s stock worth $55,000 after purchasing an additional 320 shares in the last quarter. Finally, TD Private Client Wealth LLC raised its position in shares of Hawkins by 242.5% during the 3rd quarter. TD Private Client Wealth LLC now owns 459 shares of the specialty chemicals company’s stock worth $59,000 after purchasing an additional 325 shares during the last quarter. Institutional investors and hedge funds own 69.71% of the company’s stock.

Hawkins Company Profile

Hawkins, Inc operates as a specialty chemical and ingredients company in the United States. It operates through three segments: Industrial, Water Treatment, and Health and Nutrition. The Industrial segment offers industrial chemicals, products, and services to agriculture, chemical processing, electronics, energy, food, pharmaceutical, and plating industries.